These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2554503)

  • 1. An objective evaluation of the clinical potential of low molecular weight heparins in the prevention of thromboembolism.
    Haas S; Blümel G
    Semin Thromb Hemost; 1989 Oct; 15(4):424-34. PubMed ID: 2554503
    [No Abstract]   [Full Text] [Related]  

  • 2. Low molecular weight heparins: prophylaxis of venous thromboembolism in surgical patients.
    Kakkar VV
    Semin Hematol; 1997 Oct; 34(4 Suppl 4):9-19. PubMed ID: 9399405
    [No Abstract]   [Full Text] [Related]  

  • 3. When can the patient with deep venous thrombosis begin to ambulate?
    Aldrich D; Hunt DP
    Phys Ther; 2004 Mar; 84(3):268-73. PubMed ID: 14984299
    [No Abstract]   [Full Text] [Related]  

  • 4. Antithrombotic defense during the postoperative period. Clinical documentation of low molecular weight heparin.
    Welzel D; Wolf H; Koppenhagen K
    Arzneimittelforschung; 1988 Jan; 38(1):120-3. PubMed ID: 2835055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of postoperative thromboembolism with a heparin- dihydroergotamine combination].
    Sándor T; Lászlo E; Magyary F; Turcsányi G; Hetényi L; Izinger E
    Orv Hetil; 1984 Feb; 125(9):519-24. PubMed ID: 6700990
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins?
    Agnelli G
    Haematologica; 1995; 80(2 Suppl):78-83. PubMed ID: 7628776
    [No Abstract]   [Full Text] [Related]  

  • 7. [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?].
    Ruiz Manzano J; Monreal M
    Med Clin (Barc); 1998 Nov; 111(18):697-9. PubMed ID: 9887434
    [No Abstract]   [Full Text] [Related]  

  • 8. Low-molecular-weight heparins in clinical practice.
    Hunt D
    South Med J; 1998 Jan; 91(1):2-10. PubMed ID: 9438394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Postoperative thromboembolism prophylaxis with a reduced low dose heparin fraction and dihydroergotamine in fixed combination (author's transl)].
    Buttermann G; Haluszczynski I; Theisinger W; Pabst HW
    MMW Munch Med Wochenschr; 1981 Jul; 123(31):1213-6. PubMed ID: 6790966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical potential of low molecular weight heparins.
    Messmore HL
    Semin Thromb Hemost; 1989 Oct; 15(4):405-8. PubMed ID: 2554501
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention of thromboembolism in digestive and abdominal surgery. New heparins].
    Samama M
    Ann Chir; 1992; 46(1):8-10. PubMed ID: 1312799
    [No Abstract]   [Full Text] [Related]  

  • 12. Prophylaxis of postoperative thromboembolism with low dose heparin alone or in combination with dihydroergotamine. A review.
    Lindblad B
    Acta Chir Scand Suppl; 1988; 543():31-42. PubMed ID: 3055779
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of heparin in combination with dihydroergotamine for the postoperative prevention of thrombosis in hip joint surgery].
    Liedloff H; Brauckhoff KF; Heerdegen R; Barthel W
    Z Gesamte Inn Med; 1984 Sep; 39(17):428-31. PubMed ID: 6390998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Perioperative prevention of thromboembolism with low molecular weight heparin and postoperative bleeding complications].
    Hoffman R; Largiadèr F; Brütsch HP
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():1179-84. PubMed ID: 1983509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Peroperative thromboembolism prophylaxis: low-dose heparin or low molecular weight heparin-DHE, the advantages and disadvantages. A prospective randomized study].
    Hoffmann R; Largiadèr F; Roethlin M
    Helv Chir Acta; 1987 Dec; 54(4):521-5. PubMed ID: 2833477
    [No Abstract]   [Full Text] [Related]  

  • 16. European consensus statement on the prevention of venous thromboembolism. European Consensus Conference, Windsor, U.K., November, 1991.
    Haas S
    Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S5-8; discussion S9-10. PubMed ID: 8180330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current trends in the management of postsurgical thromboembolism: the role of low molecular weight heparin.
    Bergqvist D
    Semin Thromb Hemost; 1991 Oct; 17(4):332-5. PubMed ID: 1666452
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Low-molecular-weight heparin - enoxaparin (clexane) in the prevention of thromboembolic complications in surgical patients].
    Zabolotskikh IB; Sin'kov SV; Klevko VA
    Anesteziol Reanimatol; 2001; (2):70-5. PubMed ID: 11494909
    [No Abstract]   [Full Text] [Related]  

  • 20. [5 years' general drug prevention of thromboembolism in general surgery. Comparison of personal experiences with results from the literature].
    Voigt J; Lennert K; Hedderich J
    Fortschr Med; 1984 May; 102(20):562-4. PubMed ID: 6735335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.